BRACELET-1 (PrE0113): A study to assess overall response rate by inducing an inflammatory phenotype in metastatic breast cancer with the oncolytic reovirus pelareorep in combination with anti-PD-L1 avelumab and paclitaxel

Miller et al, Previously presented at the 2020 Virtual San Antonio Breast Cancer Symposium® – 43rd Annual Meeting;  San Antonio, TX, USA; December 9-11, 2020